| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f84747e8d08b1023763356d0e7d1db68 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-10 |
| filingDate |
2007-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f327f37e62cc8cd9de2c160e9ce55c22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af70139b27a19bf3b9b1147a9dd2127d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5350558c7d4a9c468c0ee056c2796fe5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_921548d51f94e049205e0a2a373843bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb23c408da4a522d560de824e7fb9e13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60b4472d31672f860c0310e575b4ccb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e01518858df65c0b4e28fb22a8debcdc |
| publicationDate |
2009-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7625946-B2 |
| titleOfInvention |
Propargylated aminoindans, processes for preparation, and uses thereof |
| abstract |
This invention provides compounds having the structure: n n n n n n n n n n wherein R 1 is methyl and R 2 is H, or R 1 is ethyl and R 2 is hydroxymethyl; n R 3 is H or propargyl; and n R 4 is either H or t-butyloxycarbonyl;n nor an enantiomer or a pharmaceutically acceptable salt thereof. This invention further provides the use of a therapeutically effective amount of such compounds to treat a subject afflicted with a psychiatric disorder, Parkinson's disease, Alzheimer's disease, dementia, or a neurological disorder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012027471-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9114135-B2 |
| priorityDate |
2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |